TY - JOUR
T1 - Pharmacokinetics of carminomycin in man
T2 - Biweekly schedule vs single dose every three weeks
AU - Weenen, H.
AU - Pinedo, H. M.
AU - De Planque, M. M.
AU - Ten Bokkel Huinink, W. W.
AU - McVie, J. G.
AU - Lankelma, J.
PY - 1984
Y1 - 1984
N2 - Carminomycin was administered to five patients at a dose of 7.5 mg/m2 twice weekly. Plasma and urine samples were obtained during two subsequent 72-hr periods following drug administration, and assayed for carminomycin (C) and carminomycinol (Col) by HPLC with fluorescence detection. Distribution of carminomycin was rapid and drug levels decreased below the detection limit (5 × 10-9 M) within 24 hr. Carminomycinol appeared very quickly and surpassed carminomycin levels in 10 min-4 hr, disappearing very slowly, with a half-life of 40-98 hr. No major differences in pharmacokinetic behavior were found when comparing the five patients in this study with patients who received 18 mg/m2, as described in a previous report. After the second dose of carminomycin in the 7.5 mg/m2 twice weekly schedule, however, carminomycin pharmacokinetics were found to be altered in comparison with the first dose, the most pronounced difference being an increase in the t 1 2 for Col from 65 ± 28 to 173 ± 81 hr.
AB - Carminomycin was administered to five patients at a dose of 7.5 mg/m2 twice weekly. Plasma and urine samples were obtained during two subsequent 72-hr periods following drug administration, and assayed for carminomycin (C) and carminomycinol (Col) by HPLC with fluorescence detection. Distribution of carminomycin was rapid and drug levels decreased below the detection limit (5 × 10-9 M) within 24 hr. Carminomycinol appeared very quickly and surpassed carminomycin levels in 10 min-4 hr, disappearing very slowly, with a half-life of 40-98 hr. No major differences in pharmacokinetic behavior were found when comparing the five patients in this study with patients who received 18 mg/m2, as described in a previous report. After the second dose of carminomycin in the 7.5 mg/m2 twice weekly schedule, however, carminomycin pharmacokinetics were found to be altered in comparison with the first dose, the most pronounced difference being an increase in the t 1 2 for Col from 65 ± 28 to 173 ± 81 hr.
UR - http://www.scopus.com/inward/record.url?scp=0021274941&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021274941&partnerID=8YFLogxK
U2 - 10.1016/0277-5379(84)90164-0
DO - 10.1016/0277-5379(84)90164-0
M3 - Article
C2 - 6540192
AN - SCOPUS:0021274941
SN - 0277-5379
VL - 20
SP - 915
EP - 918
JO - European Journal of Cancer and Clinical Oncology
JF - European Journal of Cancer and Clinical Oncology
IS - 7
ER -